Investigational BACE inhibitors for the treatment of Alzheimer's disease

BP Imbimbo, M Watling - Expert Opinion on Investigational Drugs, 2019 - Taylor & Francis
Introduction: The amyloid hypothesis of Alzheimer's disease (AD) states that brain
accumulation of amyloid-β (Aβ) oligomers and soluble aggregates represents the major …

BACE1: More than just a β‐secretase

HA Taylor, L Przemylska, EM Clavane… - Obesity …, 2022 - Wiley Online Library
Summary β‐site amyloid precursor protein cleaving enzyme‐1 (BACE1) research has
historically focused on its actions as the β‐secretase responsible for the production of β …

Functions of amyloid precursor protein in metabolic diseases

Y Guo, Q Wang, S Chen, C Xu - Metabolism, 2021 - Elsevier
Amyloid precursor protein (APP) is a transmembrane precursor protein that is widely
expressed in the central nervous system and peripheral tissues in the liver and pancreas …

[HTML][HTML] Amyloid-beta and tau protein beyond Alzheimer's disease

M Abyadeh, V Gupta, JA Paulo… - Neural Regeneration …, 2024 - journals.lww.com
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to
play key roles in Alzheimer's disease pathogenesis and are considered the main …

[HTML][HTML] Metformin a potential pharmacological strategy in late onset Alzheimer's disease treatment

SR Poor, M Ettcheto, A Cano, E Sanchez-Lopez… - Pharmaceuticals, 2021 - mdpi.com
Alzheimer's disease (AD) is one of the most devastating brain disorders. Currently, there are
no effective treatments to stop the disease progression and it is becoming a major public …

Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models

L Ferré-González, A Lloret, C Cháfer-Pericás - Progress in Lipid Research, 2023 - Elsevier
Alzheimer's disease (AD) diagnosis is based on invasive and expensive biomarkers.
Regarding AD pathophysiological mechanisms, there is evidence of a link between AD and …

[HTML][HTML] The involvement of peripheral and brain insulin resistance in late onset Alzheimer's dementia

J Folch, J Olloquequi, M Ettcheto… - Frontiers in aging …, 2019 - frontiersin.org
Nowadays, Alzheimer's disease (AD) is a severe sociological and clinical problem. Since it
was first described, there has been a constant increase in its incidence and, for now, there …

[HTML][HTML] Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

L Ferré-González, Á Balaguer, M Roca, A Ftara… - Scientific reports, 2024 - nature.com
Lipids are the major component of the brain with important structural and functional
properties. Lipid disruption could play a relevant role in Alzheimer's disease (AD). Some …

The common genes involved in the pathogenesis of Alzheimer's disease and type 2 diabetes and their implication for drug repositioning

X Yuan, H Wang, F Zhang, M Zhang, Q Wang… - Neuropharmacology, 2023 - Elsevier
Abstract Background The prevalences of Alzheimer's disease (AD) and type 2 diabetes
(T2D) continuously increase with the aging of world population. Clinical and epidemiological …

[HTML][HTML] Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

PJ Meakin, BM Coull, Z Tuharska… - The Journal of …, 2020 - Am Soc Clin Investig
Diabetes, obesity, and Alzheimer's disease (AD) are associated with vascular complications
and impaired nitric oxide (NO) production. Furthermore, increased β-site amyloid precursor …